Skip to main content
Download PDF

Health-related quality of life and its determinant factors in Thai children with cancer: parents vs. children perspectives

BMC Pediatrics volume 24, Article number: 531 (2024) Cite this article

Abstract

Background

Health-related quality of life (HRQOL) is a vital assessment to demonstrate the achievement in pediatric cancer care parallels that of medical treatment. The Pediatric Quality of Life Inventory (PedsQL) 3.0 Cancer Module in the Thai Version has become a standard tool to access the HRQOL among Thai children with cancer and their families. This study aimed to explore the HRQOL and factors related to HRQOL among pediatric oncology patients using the PedsQL 3.0 Cancer Module.

Methods

In 2018–2019, a single-institution, cross-sectional study was conducted among children with cancer and their families in Bangkok, Thailand. A paired-sample t-test was performed to evaluate the differences between the HRQOL scores of the child and parents' reports. Linear regression was used to evaluate factors associated with HRQOL and which particular domains of the PedsQL 3.0 Cancer Module were influenced.

Results

Eighty-five children with cancer and their families were enrolled. The patients’ mean age was 10.82 ± 5.48 years. The most common cancer types included acute lymphoblastic leukemia (n = 32, 67%), central nervous system tumors (n = 13, 15%), osteosarcoma (n = 10, 27%) and neuroblastoma (n = 9, 24%), in rank. The mean HRQOL scores in child and parent reports were 74.37 ± 15.7 and 70.42 ± 17.15, respectively (p = 0.034). Factors negatively correlated to HRQOL in parent reports were the number of outpatient visits (p = 0.019) and hospital admissions (p = 0.002). The number of hospitalizations was the only independent factor that affected HRQOL (p = 0.044). The number of outpatient visits and/or hospital admissions was influenced by pain and hurt, nausea, procedural anxiety and communication domains (p < 0.05). Only the number of hospitalizations was an independent factor influencing the procedural anxiety domain in HRQOL (p = 0.005).

Conclusion

HRQOL among Thai children with cancer was desirable from both children's and parent's perspectives. Differences between child and parent HRQOL scores were observed. The number of outpatient visits and hospital admissions affected HRQOL, particularly in the procedural anxiety aspect.

Trial registration

Thai Clinical Trials Registry (TCTR) Number: TCTR20200904001 (04/09/2020), https://www.thaiclinicaltrials.org/.

Peer Review reports

Introduction

Childhood cancer is one of the major public health problems, with an overall incidence rate of 140.6 per million person-years globally [1]. Different types of cancer require specific treatment plans according to the disease and its severity. The wide range of treatment modalities includes systemic chemotherapy, surgery, radiation, immunotherapy and hematopoietic stem cell transplantation. Although the increased survival rate of up to 80% [2] underlines the success of advanced medical care for devastating diseases, cancer treatment among children remains a major physical and psychological stressor for both patients and families.

The World Health Organization (WHO) defines health, “as a state of complete physical, mental and social well-being, not merely the absence of disease or infirmity” [3]. Therefore, measuring health with the presence or absence of diseases remains insufficient. Physical and biochemical measurements may indicate only disease and treatment strategies. However, these do not demonstrate the patient’s well-being and mental health, which should be considered as an important health dimension called the quality of a person’s life.

Quality of life (QOL) constitutes “an overall sense of well-being including aspects of happiness and satisfaction with life as a whole” [3]. Health-related Quality of life (HRQOL) is a multidimensional aspect that defines how disease and treatment affect a patient’s sense of overall function and well-being [4]. Also, the clinical symptoms of cancer and the aggressive treatment substantially impact a patient's life in multiple aspects, which may affect HRQOL. As a result, children and families have experienced a reduction in their QOL after being diagnosed with cancer and treatment has been initiated [5]. In Pakistan, cancer patients exhibited a lower HRQOL than healthy youngsters [6]. For these reasons, the intention of cancer treatment currently is to cure the disease and improve the QOL of patients and families.

To achieve this goal, an assessment and understanding of HRQOL among children with cancer both from the patient themselves and their family's perspectives is crucial. Our study aims to illustrate HRQOL among Thai children with cancer using a standard instrumental questionnaire, The Pediatric Quality of Life Inventory (PedsQL) 3.0 Cancer Module, Thai Version [7], and explore factors associated with HRQOL. The results would establish adapted treatment strategies to achieve patient outcomes of both physical and mental health for Thai children with cancer, which may be further expanded to neighbors having a similar context perspective.

Methods

Participants

Oncology patients aged 2 to 18 years and their parents or guardians, who were treated primarily at the Division of Hematology-Oncology, Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand from May 1, 2018, to November 30, 2019, were eligible for this study. Patients with terminal illnesses, developmental disorders, intellectual disabilities, learning disorders, in palliative care or illiterate were excluded from the study. All participants and their legal guardians were provided informed consent and assented to participate in the study.

Instrument

The original version of the PedsQL 3.0 Cancer Module was translated to Thai under a full linguistic validation process. The PedsQL 3.0 Cancer Module, Thai version was approved by the Mapi Research Trust for academic purposes, with evidence of excellent internal consistency among child and parent reports (0.92 and 0.94, respectively) [7].

The PedsQL 3.0 Cancer Module, Thai version was designed to evaluate the QOL among children and young adults with cancer aged 2 to 25 years. The PedsQL 3.0 Cancer Module has two parallel versions (child and parent forms) in each different age group: child (5–7, 8–12, 13–18 and 18–25 years) and parent (2–4, 5–7, 8–12, 13–18 and 18–25 years) reports. The PedsQL 3.0 Cancer Module consists of 8 domains and a total of 27 items: 1) pain and hurt (2 items), 2) nausea (5 items), 3) procedural anxiety (3 items), 4) treatment anxiety (3 items), 5) worry (3 items), 6) cognitive problems (5 items), 7) perceived physical appearance (3 items) and 8) communication (3 items). The child and parent rate a score in each item based on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = often, and 4 = almost always). The 5- to 7-year child report is exceptional; the child rates a score in each item based on a 3-point Likert scale according to a visual aid, (0 = never/happy face, 2 = sometimes/neutral face, and 4 = almost always/sad face). The score in each item was reverse-scored and linearly transformed to a 0 to 100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0). Scores in each domain were calculated as the sum of the items divided by the number of items answered. Higher scores indicated a better HRQOL.

Procedures

After informed consent and assent forms were obtained, parents then completed the demographic data information and PedsQL 3.0 Cancer Module, Thai Version. For patients aged 2 to 4 years, only parents filled out the questionnaires. Children aged ≥ 5 years completed the PedsQL 3.0 Cancer Module, Thai Version separately from their parents. Children aged 5 to 7 years completed the questionnaires with support from a research assistant to ensure reading competency and to clarify each question. Children aged 8 to 18 completed the questionnaires independently or with support when needed.

This study comprised a secondary analysis of data from the related cohort of Sudnawa KK, et al. [7] and was approved by the Institutional Review Board, Royal Thai Army Medical Department according to the ethics principles of the Declaration of Helsinki (1964) and its revision (reference number: IRBRTA 700/2561). The study was also registered and approved by the Thai Clinical Trials Registry (TCTR https://www.thaiclinicaltrials.org/), number TCTR20200904001 (04/09/2020).

Statistical analysis

Demographic data were analyzed using descriptive statistics and presented as mean with standard deviation (SD) for continuous variables and demonstrated as frequency and percentage for categorical variables. A paired-sample t-test was conducted to evaluate the differences between the HRQOL scores of the child and parent reports from each domain of the PedsQL 3.0 Cancer Module. Univariate and multivariate linear regression were used to evaluate factors correlated to HRQOL and which particular domains of the PedsQL3.0 Cancer Module were influenced. Statistical significance was considered at p < 0.05. Statistical analysis was performed using IBM SPSS Software for Windows, Version 23.0 (Armonk, NY: IBM Corp., USA).

Results

Patient characteristics

Eighty-five eligible children with cancer and their parents participated in the study. Patient demographic data including age, sex, diagnosis, disease and treatment status, hospital visits, school attendance, parental marriage status and household incomes are summarized in Table 1.

Table 1 Patient demographic data (n = 85)
Full size table

The male to female ratio was 3:2, and the mean age of patients was 10.8 ± 5.5 years. The mean duration of disease from diagnosis to assessment was 4.99 ± 4.96 years. The most common cancer types were acute lymphoblastic leukemia (ALL), brain or central nervous system (CNS) tumors, osteosarcoma, neuroblastoma and chronic myeloid leukemia, in rank. Four (4.7%) patients were in advanced stage. Most participants were newly diagnosed (70.6%), in remission (22.4%), and in relapse/refractory (7%) of disease, in rank. Therefore, 77.6% of patients were in the treatment process while 22.4% of patients had completed treatment. The majority of treatments received were chemotherapy (62.4%) and surgery (15.3%). Treatment complications occurred for 81.2%, with mostly encountered with electrolyte imbalance (69.4%), followed by febrile neutropenia (43.5%). The number of monthly outpatient visits and hospitalizations totaled 1.3 ± 1.3 and 1.0 ± 1.3, respectively.

Fifty-four (63.5%) patients attended school, of which 57.4% studied in primary school or lower and 42.6% studied in or higher than secondary school level. Most parents were married (81.2%) and still lived together with household monthly incomes of less than 15,000 THB (38.8%) (Table 1).

HRQOL among children and parents

Overall, children with cancer reported higher HRQOL scores of the PedsQL 3.0 Cancer Module compared with those found in parent reports, except for the perceived physical appearance and communication domains. The highest HRQOL scores of the PedsQL 3.0 Cancer Module in child reports were observed in the treatment anxiety domain (88.15 ± 17.37), while the nausea domain (78.98 ± 18.99) had the highest HRQOL scores in parent reports. On the contrary, the lowest HRQOL scores in child reports were observed in the cognitive problems domain (66.31 ± 22.26), while the worry domain (55.34 ± 30.37) had the lowest HRQOL scores in parent reports.

However, statistically significant differences were noted between child and parent reports on procedural anxiety (70.05 ± 26.67 vs. 60.03 ± 25.6, p = 0.003), treatment anxiety (88.15 ± 17.37 vs. 76.82 ± 26.7, p = 0.001), worry (66.67 ± 25.59 vs. 55.34 ± 30.37, p = 0.003) and total score (74.37 ± 15.7 vs. 70.42 ± 17.15, p = 0.034) (Supplementary Table 1).

Factors associated with overall HRQOL among children and parents

From the parent report, patients having completed the treatment were positively correlated to the total HRQOL score (β = 9.34, p = 0.039). On the contrary, the number of monthly hospitalizations (β = -4.49, p = 0.002) and number of monthly outpatient visits (β = -3.53, p = 0.019) were negatively correlated to the total HRQOL score (Table 2). Other factors including age, sex, duration of disease, cancer type, treatment, febrile neutropenia occurrence, school or family factors were unassociated with the HRQOL.

Table 2 Univariate analysis of factors correlated with HRQOL scores of PedsQL 3.0 Cancer Modulebetween children and parents
Full size table

Using multivariate analysis, only the number of monthly hospitalizations remained independently, negatively correlated to the total HRQOL score from the parent reports (β = -5.77, p = 0.044) (Table 3).

Table 3 Multivariate analysis of factors associated with total HRQOL scores of PedsQL 3.0 Cancer Module between children and parents
Full size table

Factors associated with individual domains of HRQOL among parents

Each domain of the PedsQL 3.0 Cancer Module parent report was analyzed to determine whether the number of monthly hospitalizations, outpatient visits or treatment with chemotherapy correlated to HRQOL. The number of outpatient visits and/or hospital admissions was influenced by pain and hurt, nausea, procedural anxiety and communication domains (p < 0.05). Treatment with chemotherapy was influenced by pain and hurt and procedural anxiety (p < 0.05). Only the number of monthly hospitalizations remained independent and significantly correlated to the procedure anxiety domain (β = -13.2, p = 0.005) (Fig. 1 and Supplementary Table 2).

Fig. 1
figure 1

Forest plot shows multivariate analysis factors correlated with HRQOL scores of PedsQL 3.0 Cancer Module parent reports in pain and hurt, nausea, procedural anxiety, and communication domains

Full size image

Discussion

HRQOL assessed by PedsQL3.0 Cancer Module, Thai version from parent and child reports received mean total scores of 70.4 and 74.4, respectively, which was comparable with other countries either in resource-available or limited-resource settings [8,9,10,11,12,13,14,15]. However, the total HRQOL scores in this study were higher than those of related studies [6, 16], which had fewer participants comparing between healthy children and children with cancer [6] or in hospitalized patients [16]. On the other hand, our study had slightly lower scores than those of the study of Ocak E, et al., [17] enrolling only children with leukemia in a younger age range (Table 4).

Table 4 Assessment of HRQOL scores of PedsQL 3.0 Cancer Module in literature review
Full size table

A strong agreement between child and parent reports was found in observable functioning or physical HRQOL domains [7]. Nevertheless, a disagreement was detected in nonobservable functioning or emotional or social HRQOL domains. In general, patients themselves reported higher HRQOL scores of the PedsQL 3.0 Cancer Module compared with parents, except for the perceived physical appearance and communication domains. These discordances were similarly illustrated in related studies by Sand P, et al. [9] and Tomlinson, D et al. [18]. The treatment consequences definitely change physical appearance such as hair loss, surgical scars or extremity loss which negative effect to patient emotions [19]. Physical appearance perception comprises internalized and emotional sensations that may be either difficult to interpret or considered less sentimental by the parents. Marginean CO et al. [20] reported that children were not satisfied with the amount of time their doctor communicated with them. These underline the communication between physicians and pediatric patients remains insufficient or inappropriate, especially in serious situations which children may be left behind. Good communication and emotional supports between children, their care givers and doctors may better comprehend the patients’ emotions and support for each other.

From the parents' perspectives, higher score domains were reported for “Nausea” and “Pain and hurt.” This may imply that symptomatic and supportive care programs in Thailand was sufficient to provide positive emotions for parents, especially the appropriate protocol for bedside invasive procedural sedation among patients undergoing multiple painful procedures such as bone marrow procedures or lumbar puncture [21, 22]. Moreover, providing proper analgesics and anti-emetics can improve HRQOL [23,24,25], particularly in patients who require repeated or multiple invasive procedures for diagnosis and treatment [21, 22], ranging from weekly intrathecal chemotherapy during the induction phase to every three months during the maintenance phase of ALL treatment [26]. A higher HRQOL score in the communication domain was demonstrated in parent reports rather than child reports corresponding to many studies [8, 11, 17]. It conveys that the communication between families and medical teams particularly shared decision-making will benefit and improve HRQOL among children with cancer [27].

Some aspects were contradictory between parent and child perspectives, for example, “Treatment anxiety” received superior HRQOL scores in child reports compared with those in parent reports, which was similar to related studies [9, 10, 13, 14, 17]. The lower score domains from the parent reports included “Worry” and “Procedural anxiety” whereas “Worry” and “Cognitive problems” were addressed as the lowest score domain in child reports which was parallel to related studies [8, 10, 12, 14, 16, 17]. Anxiety and depression-related findings were frequently reported among children with cancer [28, 29]. Screening tests for early detection of mood problems and early intervention such as enhancing communication skills or psychotherapy will support patients and families with cancer [30].

Cognitive problems among children with cancer may be directly caused by specific types of cancer and treatment, such as CNS tumors, cranial irradiation, chemotherapy crossing blood–brain barriers or prolonged hospitalization leading children to incompetency in school activities [31, 32]. Early detection of cognitive problems among pediatric oncology patients along with broad strategies such as educational intervention, and cognitive training are essential to remediate cognitive and learning dysfunction [31, 33].

Interestingly, we found that the total HRQOL score was positively correlated to completed treatment status. This finding corresponded to that of Meeske K et al., [34] which found that patients with CNS tumors and ALL who were undergoing treatment had lower HRQOL scores of PedsQL™ 3.0 cancer module compared to those who had completed treatment. This result can be attributed to the absence of hospitalization, treatment-related anxiety, and unpleasant emotions. Furthermore, we addressed that the number of monthly in- and outpatient visits were negative indicators correlating to the HRQOL score. Hospitalizations subsequently remained independent and negatively correlated to the "Procedure anxiety" domain from the parent report. However, Baggott CR et al. [35] identified that pediatric oncology patients with prolonged hospitalization possibly had a higher nausea score assessed by PedsQL™ 3.0 cancer module, but no correlation was observed in the total or “Procedure anxiety” HRQOL score. These contradicting results may stem from different intravenous catheterization access levels between resource-available and resource-limited settings. In resource-available countries, central venous catheters (CVC) always applied to all children with cancer needing repeated systemic chemotherapy, in contrast with low and middle income countries in which patients regularly received services for repeated peripheral venous catheters at each single visit [21]. This made patients more anxious when hospitalization was required. CVC placement should be considered among patients requiring multiple invasive and distressing procedures or prolonged treatment, especially for inhouse patients. Moreover, early detection of infectious complications which is the most common cause of prolonged and increased number of hospitalizations, may increase HRQOL among children with cancer.

Nonpharmacologic treatments, either hypnosis or nonhypnosis interventions, may reduce procedural anxiety for pediatric inpatients [36], particularly those younger than five years who reported a strong association with “Procedural anxiety” [8, 14, 37, 38]. Robson PC, et al. [37] reported lower household income correlated to poorer child’s HRQOL in the US, which was not identified in our study. This observation may be explained by the accessible and successful implementation of Thailand's universal health coverage applying to all Thais regardless of different income levels [39].

This is the very first study to initiate the assessment of the HRQOL among Thai children with cancer using the standard tool of PedsQL 3.0 Cancer Module in the Thai Version, applied in both parent and child reports. Results will elucidate HRQOL in children with cancer and further generate an appropriate institutional policy that may expand to the whole nation to improve the QOL for Thai children with cancer.

Limitations of the study

The relatively small sample size in some age groups with a single institution may have affected the generalization and power to identify outcomes. However, the study's focus on the Thai population may be of interest to the Asian-Pacific community. Additional factors such as delayed diagnosis, should be further explored to determine their impact on HRQOL. Longitudinal HRQOL follow-up studies in multicenter settings or focus-group studies are recommended to gain a deeper understanding and better comprehension of HRQOL among Thai children with cancer.

Conclusion

HRQOL among Thai children with cancer was desirable from both children and parents' perspectives, comparable with most countries around the world. Differences between child and parent HRQOL scores were observed.

Cognitive issues and unpleasant emotions, especially worries, impact HRQOL. The frequency of outpatient visits and hospitalizations diminished HRQOL and was further associated with procedure anxiety.

This study emphasizes the importance of assessing the HRQOL and raises concerns regarding patient and family support services, appropriate protocols for chemotherapy-induced nausea and vomiting, bedside invasive procedural sedation to reduce nausea and vomiting, as well as worrisome and treatment-related anxiety. Early screening and early intervention can reduce hospitalizations. Good communication with early psychological consults along with in-house educational approaches that will enhance the patient’s cognitive function should be applied among children with cancer.

Availability of data and materials

The datasets generated or analyzed during the current study are not publicly available due to privacy or ethics restrictions. The data are available from the corresponding author upon reasonable request.

Abbreviations

ALL:

Acute lymphoblastic leukemia

CNS:

Central nervous system

CVC:

Central venous catheter

HRQOL:

Health-related quality of life

PedsQL:

The Pediatric Quality of Life Inventory

QOL:

Quality of life

SD:

Standard deviation

TCTR:

Thai Clinical Trials Registry

THB:

Thai baht

WHO:

World Health Organization

References

  1. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW. Recent progress in the treatment of cancer in children. CA Cancer J Clin. 2021;71(4):315–32.

    Article  PubMed  Google Scholar 

  3. Taylor VR. Measuring healthy days: Population assessment of health-related quality of life. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health; 2000.

  4. Sitlinger A, Zafar SY. Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am. 2018;27(4):675–84.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Klassen AF, Anthony SJ, Khan A, Sung L, Klaassen R. Identifying determinants of quality of life of children with cancer and childhood cancer survivors: a systematic review. Support Care Cancer. 2011;19(9):1275–87.

    Article  PubMed  Google Scholar 

  6. Chaudhry Z, Siddiqui S. Health related quality of life assessment in Pakistani paediatric cancer patients using PedsQL 4.0 generic core scale and PedsQL cancer module. Health Qual Life Outcomes. 2012;10:52.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sudnawa KK, Yeepae J, Photia A, Rujkijyanont P, Traivaree C, Monsereenusorn C. The Reliability of the Thai version of Health-Related Quality of Life Questionnaire: PedsQL 3.0 Cancer Module. Glob Pediatr Health. 2022;9:2333794X221092738.

    PubMed  PubMed Central  Google Scholar 

  8. Alabbas F, Elyamany G, Alkhayat N, AlShahrani M, Ibrahim W, Elborai Y, et al. Assessment of Health-related Quality of Life in Saudi Children with Cancer. Health Serv Insights. 2021;14:11786329211029352.

    PubMed  PubMed Central  Google Scholar 

  9. Sand P, Kleiberg AN, Kljajic M, Lannering B. The reliability of the health related quality of life questionnaire PedsQL 3.0 cancer module in a sample of Swedish children. BMC Pediatr. 2020;20(1):497.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Santos S, Crespo C, Canavarro MC, Fernandes A, Batalha L, de Campos D, et al. Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module. Health Qual Life Outcomes. 2016;14:20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Abu-Saad Huijer H, Sagherian K, Tamim H. Quality of life and symptom prevalence in children with cancer in Lebanon: the perspective of parents. Ann Palliat Med. 2013;2(2):59–70.

    PubMed  Google Scholar 

  12. Ji Y, Chen S, Li K, Xiao N, Yang X, Zheng S, et al. Measuring health-related quality of life in children with cancer living in Mainland China: feasibility, reliability and validity of the Chinese Mandarin version of PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module. Health Qual Life Outcomes. 2011;9:103.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tsuji N, Kakee N, Ishida Y, Asami K, Tabuchi K, Nakadate H, et al. Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Health Qual Life Outcomes. 2011;9:22.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sitaresmi MN, Mostert S, Gundy CM, Sutaryo, Veerman AJ. Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes. 2008;6:96.

  15. Hegazy A, Al Bar H, H. Alamri S, Almahmoudi FA, Al Ghamdi WS, Abdulgader E. Quality of Life in Pediatric Cancer Patients. Journal of Advances in Medicine and Medical Research. 2019;30(10):1–11.

  16. Nunes MDR, Jacob E, Bomfim EO, Lopes-Junior LC, de Lima RAG, Floria-Santos M, et al. Fatigue and health related quality of life in children and adolescents with cancer. Eur J Oncol Nurs. 2017;29:39–46.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ocak E, Yozgat AK, Kacar D, Sucakli IA, Ozbek NY, Uneri OS, et al. Health-related Quality of Life for Children With Leukemia: Child and Parental Perceptions. J Pediatr Hematol Oncol. 2021;43(1):e56–63.

    Article  PubMed  Google Scholar 

  18. Tomlinson D, Plenert E, Dadzie G, Loves R, Cook S, Schechter T, et al. Reasons for disagreement between proxy-report and self-report rating of symptoms in children receiving cancer therapies. Support Care Cancer. 2021;29(7):4165–70.

    Article  PubMed  Google Scholar 

  19. Sadruddin MM, Hameed-Ur-Rehman M. Understanding the perceptions of children battling cancer about self and others through drawing. South Asian J Cancer. 2013;2(3):113–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mărginean CO, Meliţ LE, Chinceşan M, Mureşan S, Georgescu AM, Suciu N, et al. Communication skills in pediatrics - the relationship between pediatrician and child. Medicine (Baltimore). 2017;96(43): e8399.

    Article  PubMed  Google Scholar 

  21. Monsereenusorn C, Malaithong W, Lertvivatpong N, Photia A, Rujkijyanont P, Traivaree C. The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial. Pediatr Hematol Oncol. 2022;39(8):681–96.

    Article  CAS  PubMed  Google Scholar 

  22. Monsereenusorn C, Rujkijyanont P, Traivaree C. The clinical effect of fentanyl in comparison with ketamine in analgesic effect for oncology procedures in children: a randomized, double-blinded, crossover trial. J Med Assoc Thai. 2015;98(4):358–64.

    PubMed  Google Scholar 

  23. Ballatori E, Roila F. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes. 2003;1:46.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yang P, Sun LQ, Pang D, Ding Y. Quality of life in cancer patients with pain in beijing. Chin J Cancer Res. 2012;24(1):60–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ruktrirong J, Traivaree C, Monsereenusorn C, Photia A, Lertvivatpong N, Rujkijyanont P. Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial. Pediatr Blood Cancer. 2021;68(6): e29002.

    Article  CAS  PubMed  Google Scholar 

  26. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lin B, Gutman T, Hanson CS, Ju A, Manera K, Butow P, et al. Communication during childhood cancer: Systematic review of patient perspectives. Cancer. 2020;126(4):701–16.

    Article  PubMed  Google Scholar 

  28. Al-Saadi LS, Chan MF, Al-Azri M. Prevalence of Anxiety, Depression, and Post-Traumatic Stress Disorder among Children and Adolescents with Cancer: A Systematic Review and Meta-Analysis. J Pediatr Hematol Oncol Nurs. 2022;39(2):114–31.

    PubMed  Google Scholar 

  29. Yardeni M, Abebe Campino G, Hasson-Ohayon I, Basel D, Hertz-Palmor N, Bursztyn S, et al. Trajectories and risk factors for anxiety and depression in children and adolescents with cancer: A 1-year follow-up. Cancer Med. 2021;10(16):5653–60.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lazor T, De Souza C, Urquhart R, Serhal E, Gagliardi AR. Few guidelines offer recommendations on how to assess and manage anxiety and distress in children with cancer: a content analysis. Support Care Cancer. 2021;29(5):2279–88.

    Article  PubMed  Google Scholar 

  31. Castellino SM, Ullrich NJ, Whelen MJ, Lange BJ. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. J Natl Cancer Inst. 2014;106(8):dju186.

  32. Hutchinson AD, Pfeiffer SM, Wilson C. Cancer-related cognitive impairment in children. Curr Opin Support Palliat Care. 2017;11(1):70–5.

    Article  PubMed  Google Scholar 

  33. Mayo SJ, Lustberg M, H MD, Nakamura ZM, Allen DH, Von Ah D, et al. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer. 2021;29(6):2821–40.

  34. Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer. 2004;101(9):2116–25.

    Article  PubMed  Google Scholar 

  35. Baggott CR, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper B, et al. An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer. 2011;19(3):353–61.

    Article  PubMed  Google Scholar 

  36. Nunns M, Mayhew D, Ford T, Rogers M, Curle C, Logan S, et al. Effectiveness of nonpharmacological interventions to reduce procedural anxiety in children and adolescents undergoing treatment for cancer: A systematic review and meta-analysis. Psychooncology. 2018;27(8):1889–99.

    Article  PubMed  Google Scholar 

  37. Robson PC, Dietrich MS, Akard TF. Associations of Age, Gender, and Family Income with Quality of Life in Children With Advanced Cancer. J Pediatr Oncol Nurs. 2021;38(4):254–61.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Dupuis LL, Lu X, Mitchell HR, Sung L, Devidas M, Mattano LA Jr, et al. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children’s Oncology Group. Cancer. 2016;122(7):1116–25.

    Article  PubMed  Google Scholar 

  39. Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205–23.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledged the Mapi Research Trust for providing translational agreement approval and permission to use the Thai Version of the PedsQL 3.0 Cancer Module for academic purposes and Mrs. Supak Cae-Ngow, Office of Research and Development, Phramongkutklao Hospital, and Phramongkutklao College of Medicine for statistical analysis. The authors also thank the physicians, nurses, patients and families for participating in this study.

Funding

The funding to conduct and analyze the study was provided by the Phramongkutklao College of Medicine.

Author information

Authors and Affiliations

  1. Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand

    Khemika K. Sudnawa

  2. Phayao Hospital, Ministry of Public Health, Phayao, Thailand

    Jitthip Yeepae

  3. Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, 315 Ratchawithi Rd. Ratchathewi, Bangkok, 10400, Thailand

    Apichat Photia, Piya Rujkijyanont, Chanchai Traivaree & Chalinee Monsereenusorn

Authors
  1. Khemika K. Sudnawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jitthip Yeepae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Apichat Photia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Piya Rujkijyanont
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chanchai Traivaree
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chalinee Monsereenusorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KS contributed to conceptualizing and designing the study, interpreted data and drafted and edited the manuscript. JY was involved in patient care and collected and interpreted the data. CM contributed to patient care, conceptualized and designed the study, managed the program overall, analyzed, and interpreted data, and was a major contributor in writing the manuscript. All authors contributed to patient care, collected data, and critically reviewed and approved the final version of the manuscript.

Corresponding author

Correspondence to Chalinee Monsereenusorn.

Ethics declarations

Ethics approval and consent to participate

Written informed consent and assent forms were obtained from all participants. This study was approved by the Institutional Review Board, Royal Thai Army Medical Department (reference number: IRBRTA 700/2561) following the ethics principles of the Declaration of Helsinki (1964) including revisions.

The study was also registered and approved by the Thai Clinical Trials Registry (TCTR https://www.thaiclinicaltrials.org/), number TCTR20200904001 (04/09/2020).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sudnawa, K.K., Yeepae, J., Photia, A. et al. Health-related quality of life and its determinant factors in Thai children with cancer: parents vs. children perspectives. BMC Pediatr 24, 531 (2024). https://doi.org/10.1186/s12887-024-05010-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-05010-8

Keywords

BMC Pediatrics

ISSN: 1471-2431

Contact us